Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.

American journal of public health

Volumn 101, Issue 4, 2011, Pages 602-609

  Rothman, Sheila M ^a   Raveis, Victoria H ^b   Friedman, Anne ^b   Rothman, David J ^b  

^a Division of Sociomedical Sciences Mailman School of Public Health Columbia University New York NY USA ^*

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; INTERPERSONAL COMMUNICATION; ORGANIZATION; PATIENT ADVOCACY; POLICY; REGISTER; UNITED STATES;

DISCLOSURE; DRUG INDUSTRY; HEALTH POLICY; HUMANS; ORGANIZATIONAL OBJECTIVES; ORGANIZATIONAL POLICY; ORGANIZATIONS; PATIENT ADVOCACY; REGISTRIES; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 79955666819     PISSN: None     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2010.300027     Document Type: Article

References (0)